Auto-injectors Market Size & Share, by Product Type (Disposable, Reusable); Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis); End-Use (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers); Technology (Manual, Automatic); Route of Administration (Subcutaneous, Intramuscular) – Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3511
  • Published Date: Nov 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Auto-injectors Landscape

top-features-companies
    • Eli Lilly and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Scandinavian Health Ltd.
    • AbbVie, Inc.
    • Amgen
    • Owen Mumford
    • Ypsomed
    • Biogen Idec
    • Mylan N.V.
    • Pfizer, Inc.
    •  Sanofi
    • Stevanato Group
    • Teva Pharmaceutical

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Eli Lilly and Company announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Mounjaro (tirzepatide) injection a single molecule that activates the body's receptors for GIP and GLP-1 for people living with type 2 diabetes to assist individuals in obtaining the prescription drugs they are prescribed, and it will collaborate with physicians, insurers, and health systems to facilitate patient access to Mounjaro.
  • Stevanato Group together with Owen Mumford to expedite the Aidaptus auto-injector's manufacturing process and also provide pharmaceutical clients with pre-filled syringes so they may administer the finished product to patients.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3511
  • Published Date: Nov 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of rheumatoid arthritis and the growing government initiatives to increase awareness are the major factors driving the growth of the market.

The market size of Auto-injectors is anticipated to attain a CAGR of 17% over the forecast period, i.e., 2024-2036.

The major players in the market are Scandinavian Health Ltd., AbbVie, Inc., Amgen, Owen Mumford, Ypsomed, Biogen Idec, Mylan N.V., Pfizer, Inc., Sanofi, and Stevanato Group.

The anaphylaxis segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying